PSU Profiles
Loading...
Keywords
Last Name
Institution

Nicholas G Zaorsky, MD

TitleAssistant Professor
InstitutionCollege of Medicine
DepartmentRadiology
Address500 University Drive Hershey, PA 17033
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tchelebi L, Zaorsky N, Mackley H. Stereotactic Body Radiation Therapy in the Management of Upper GI Malignancies. Biomedicines. 2018 Jan 03; 6(1). PMID: 29301352.
      View in: PubMed
    2. Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MA, Horwitz EM. Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. J Med Imaging Radiat Oncol. 2018 Feb; 62(1):116-121. PMID: 29030906.
      View in: PubMed
    3. Zaorsky NG, Lee CT, Zhang E, Keith SW, Galloway TJ. Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis. Radiother Oncol. 2017 10; 125(1):13-20. PMID: 28843727.
      View in: PubMed
    4. Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka Y, Morton GC, Horwitz EM. The evolution of brachytherapy for prostate cancer. Nat Rev Urol. 2017 Jun 30; 14(7):415-439. PMID: 28664931.
      View in: PubMed
    5. De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Créhange G, Alongi F, Zaorsky N, Ozsahin M. Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. Prostate. 2017 Jul; 77(10):1160-1166. PMID: 28594087.
      View in: PubMed
    6. Wang HH, Deng L, Wen QL, Zhang CZ, Zaorsky NG, Zhang BL, Chen J, Zeng XL, Cui YL, Shi YY, Hou HL, Wang W, Jiang B, Wang J, Pang QS, Zhao LJ, Yuan ZY, Wang P, Meng MB. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer. Oncotarget. 2017 Sep 08; 8(38):62998-63013. PMID: 28968966.
      View in: PubMed
    7. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):437-454. PMID: 29114613.
      View in: PubMed
    8. Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE. Causes of death among cancer patients. Ann Oncol. 2017 02 01; 28(2):400-407. PMID: 27831506.
      View in: PubMed
    9. Yoo SK, Ahmed AA, Ileto J, Zaorsky NG, Deville C, Holliday EB, Wilson LD, Jagsi R, Thomas CR. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015. Int J Radiat Oncol Biol Phys. 2017 Oct 01; 99(2):280-285. PMID: 28366578.
      View in: PubMed
    10. Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2017 Feb; 53:47-52. PMID: 28063304.
      View in: PubMed
    11. Johnson ME, Zaorsky NG, Martin JM, Ruth K, Greenberg RE, Uzzo RG, Hayes SB, Smaldone MC, Kutikov A, Viterbo R, Chen DY, Hallman MA, Sobczak ML, Horwitz EM. Patient reported outcomes among treatment modalities for prostate cancer. Can J Urol. 2016 Dec; 23(6):8535-8545. PMID: 27995848.
      View in: PubMed
    12. Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM. Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. Am J Clin Nutr. 2016 Dec; 104(6):1583-1593. PMID: 27797706.
      View in: PubMed
    13. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):62-84. PMID: 28740916.
      View in: PubMed
    14. Zaorsky NG, Shaikh T, Ruth K, Sharda P, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DY, Horwitz EM. Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy. Clin Genitourin Cancer. 2017 Apr; 15(2):326-335.e3. PMID: 27789181.
      View in: PubMed
    15. Guo J, Zinner R, Zaorsky NG, Guo W, Lu B. Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases. J Thorac Dis. 2016 Sep; 8(9):E1028-E1031. PMID: 27747054.
      View in: PubMed
    16. Meng MB, Wang HH, Cui YL, Wu ZQ, Shi YY, Zaorsky NG, Deng L, Yuan ZY, Lu Y, Wang P. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget. 2016 Aug 30; 7(35):57391-57413. PMID: 27429198.
      View in: PubMed
    17. Zaorsky NG, Egleston BL, Horwitz EM, Dicker AP, Nguyen PL, Showalter TN, Den RB. The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer. Am J Clin Oncol. 2016 08; 39(4):321-6. PMID: 27322694.
      View in: PubMed
    18. Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future Oncol. 2016 Nov; 12(22):2643-2657. PMID: 27470145.
      View in: PubMed
    19. Zaorsky NG, Shaikh T, Murphy CT, Hallman MA, Hayes SB, Sobczak ML, Horwitz EM. Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treat Rev. 2016 Jul; 48:50-60. PMID: 27347670.
      View in: PubMed
    20. Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman MA, Meyer JE. Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early-Stage Lung Cancer. J Thorac Oncol. 2016 Jul; 11(7):1112-20. PMID: 27109322.
      View in: PubMed
    21. Shaikh T, Churilla T, Murphy C, Zaorsky NG, Haber A, Hallman M, Meyer JE. 97O: Overtreatment of patients with clinically diagnosed early stage lung cancer. J Thorac Oncol. 2016 Apr; 11(4 Suppl):S99. PMID: 27198453.
      View in: PubMed
    22. Wang HH, Zaorsky NG, Meng MB, Zeng XL, Deng L, Song YC, Zhuang HQ, Li FT, Zhao LJ, Yuan ZY, Wang P, Hao XS. Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget. 2016 Apr 05; 7(14):18135-45. PMID: 26919113; PMCID: PMC4951277.
    23. Zaorsky NG, Keith SW, Shaikh T, Nguyen PL, Horwitz EM, Dicker AP, Den RB. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2016 Mar 24. PMID: 27014930.
      View in: PubMed
    24. Wang HH, Cui YL, Zaorsky NG, Lan J, Deng L, Zeng XL, Wu ZQ, Tao Z, Guo WH, Wang QX, Zhao LJ, Yuan ZY, Lu Y, Wang P, Meng MB. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Lett. 2016 Jun 01; 375(2):349-359. PMID: 26996301.
      View in: PubMed
    25. Shaikh T, Li T, Murphy CT, Zaorsky NG, Bleicher RJ, Sigurdson ER, Carlson R, Hayes SB, Anderson P. Importance of Surgical Margin Status in Ductal Carcinoma In Situ. Clin Breast Cancer. 2016 Aug; 16(4):312-8. PMID: 26952595.
      View in: PubMed
    26. Zaorsky NG, Shaikh T, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE. What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):235-42. PMID: 26684409.
      View in: PubMed
    27. Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct; 16(13):e510-21. PMID: 26433824.
      View in: PubMed
    28. Zaorsky NG, Hallman MA, Smaldone MC. Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted". Ann Transl Med. 2015 Oct; 3(18):274. PMID: 26605320; PMCID: PMC4630560.
    29. Hawkey NM, Zaorsky NG, Galloway TJ. The role of radiation therapy in the management of sialorrhea: A systematic review. Laryngoscope. 2016 Jan; 126(1):80-5. PMID: 26152655.
      View in: PubMed
    30. Meng MB, Wang HH, Zaorsky NG, Zhao XZ, Wu ZQ, Jiang B, Song YC, Zhuang HQ, Li FT, Zhao LJ, Wang CL, Li K, Wang P, Yuan ZY. Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer. Oncotarget. 2015 Jun 20; 6(17):15690-703. PMID: 25881546; PMCID: PMC4558180.
    31. Wang LS, Murphy CT, Ruth K, Zaorsky NG, Smaldone MC, Sobczak ML, Kutikov A, Viterbo R, Horwitz EM. Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer. Cancer. 2015 Sep 01; 121(17):3010-7. PMID: 26033633; PMCID: PMC4545724.
    32. Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation. Radiother Oncol. 2015 Jun; 115(3):295-300. PMID: 26028229.
      View in: PubMed
    33. Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015; 8:437-44. PMID: 25709477; PMCID: PMC4335610.
    34. Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy. Future Oncol. 2015; 11(1):169-79. PMID: 25143028.
      View in: PubMed
    35. Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB. Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]. Expert Rev Med Devices. 2015 May; 12(3):317-27. PMID: 25540018.
      View in: PubMed
    36. Liu N, Tao Z, Blanc JM, Zaorsky NG, Sun Y, Vuagniaux G, Dicker AP, Lu B. Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro. Am J Cancer Res. 2014; 4(6):943-51. PMID: 25520882; PMCID: PMC4266726.
    37. Meng MB, Wang HH, Guo WH, Wu ZQ, Zeng XL, Zaorsky NG, Shi HS, Qian D, Niu ZM, Jiang B, Zhao LJ, Yuan ZY, Wang P. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo. Cancer Lett. 2015 Jan 28; 356(2 Pt B):985-93. PMID: 25444918.
      View in: PubMed
    38. Shaikh T, Zaorsky NG, Ruth K, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM. Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment. Brachytherapy. 2015 May-Jun; 14(3):316-21. PMID: 25454576; PMCID: PMC4424094.
    39. Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014 Sep-Oct; 13(5):456-64. PMID: 24953945.
      View in: PubMed
    40. Palmer JD, Soule BP, Simone BA, Zaorsky NG, Jin L, Simone NL. MicroRNA expression altered by diet: can food be medicinal? Ageing Res Rev. 2014 Sep; 17:16-24. PMID: 24833329.
      View in: PubMed
    41. Palmer JD, Zaorsky NG, Witek M, Lu B. Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer. J Thorac Dis. 2014 Apr; 6(4):387-98. PMID: 24688783; PMCID: PMC3968560.
    42. Liang L, Zhu J, Zaorsky NG, Deng Y, Wu X, Liu Y, Liu F, Cai G, Gu W, Shen L, Zhang Z. MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):955-60. PMID: 24606854.
      View in: PubMed
    43. Li B, Blanc JM, Sun Y, Yang L, Zaorsky NG, Giacalone NJ, Torossian A, Lu B. Assessment of M867, a selective caspase-3 inhibitor, in an orthotopic mouse model for non-small cell lung carcinoma. Am J Cancer Res. 2014; 4(2):161-71. PMID: 24660105; PMCID: PMC3960453.
    44. Zhang I, Zaorsky NG, Abraham JA, Tuluc M, Curry JM, Bar-Ad V. Chondrosarcoma of the hyoid bone: case report and review of current management options. Head Neck. 2014 Jul; 36(7):E65-72. PMID: 23720060.
      View in: PubMed
    45. Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncol. 2014 Feb; 10(3):457-74. PMID: 24559451.
      View in: PubMed
    46. Siglin J, Champ CE, Vakhnenko Y, Witek ME, Peng C, Zaorsky NG, Harrison AS, Shi W. Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):378-83. PMID: 25407858.
      View in: PubMed
    47. Zaorsky NG, Doyle LA, Hurwitz MD, Dicker AP, Den RB. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer? Expert Rev Anticancer Ther. 2014 Jan; 14(1):39-50. PMID: 24124755.
      View in: PubMed
    48. Zaorsky NG, Showalter TN. Oncology training programs: are we doing comparative effectiveness research justice? J Comp Eff Res. 2013 Nov; 2(6):573-82. PMID: 24236796.
      View in: PubMed
    49. Zaorsky NG, Den RB, Doyle LA, Dicker AP, Hurwitz MD. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer. Expert Rev Med Devices. 2013 Nov; 10(6):751-63. PMID: 24195459.
      View in: PubMed
    50. Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. High dose rate brachytherapy boost for prostate cancer: a systematic review. Cancer Treat Rev. 2014 Apr; 40(3):414-25. PMID: 24231548.
      View in: PubMed
    51. Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol. 2013 Oct; 10(10):565-79. PMID: 24018567.
      View in: PubMed
    52. Zaorsky NG, Sun Y, Wang Z, Palmer J, Fortina PM, Solomides C, Werner-Wasik M, Dicker AP, Axelrod R, Campling B, Evans N, Cowan S, Lu B. Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer Biol Ther. 2013 Oct 01; 14(10):883-7. PMID: 23917487; PMCID: PMC3926884.
    53. Zaorsky NG, Siglin J, Den RB, Keith SW, Showalter TN, Dicker AP, Bar-Ad V. The responsibilities of a chief resident in radiation oncology: results of a national survey. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):460-1. PMID: 23906932.
      View in: PubMed
    54. Zaorsky NG, Raj GV, Trabulsi EJ, Lin J, Den RB. The dilemma of a rising prostate-specific antigen level after local therapy: what are our options? Semin Oncol. 2013 Jun; 40(3):322-36. PMID: 23806497.
      View in: PubMed
    55. Zaorsky NG, Trabulsi EJ, Lin J, Den RB. Multimodality therapy for patients with high-risk prostate cancer: current status and future directions. Semin Oncol. 2013 Jun; 40(3):308-21. PMID: 23806496.
      View in: PubMed
    56. Zaorsky NG, Malatesta TM, Showalter TN, Den RB, Shi W, Anne PR, Werner-Wasik M, Dicker AP, Bar-Ad V. Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):214-5. PMID: 23498775.
      View in: PubMed
    57. Zaorsky NG, Ohri N, Showalter TN, Dicker AP, Den RB. Systematic review of hypofractionated radiation therapy for prostate cancer. Cancer Treat Rev. 2013 Nov; 39(7):728-36. PMID: 23453861; PMCID: PMC3833592.
    58. Sun Y, Nowak KA, Zaorsky NG, Winchester CL, Dalal K, Giacalone NJ, Liu N, Werner-Wasik M, Wasik MA, Dicker AP, Lu B. ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK. Mol Cancer Ther. 2013 May; 12(5):696-704. PMID: 23443800; PMCID: PMC3651772.
    59. Meng MB, Zaorsky NG, Jiang C, Tian LJ, Wang HH, Liu CL, Wang J, Tao Z, Sun Y, Wang J, Pang QS, Zhao LJ, Yuan ZY, Ping W. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiother Oncol. 2013 Mar; 106(3):317-22. PMID: 23498325.
      View in: PubMed
    60. Zaorsky NG, Patil N, Freedman GM, Tuluc M. Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis. J Breast Cancer. 2012 Dec; 15(4):478-80. PMID: 23346180; PMCID: PMC3542859.
    61. Zaorsky NG, Studenski MT, Dicker AP, Gomella L, Den RB. Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care? Cancer Treat Rev. 2013 May; 39(3):212-8. PMID: 23218442.
      View in: PubMed
    62. Zaorsky NG, Luo JJ. A case of classic raymond syndrome. Case Rep Neurol Med. 2012; 2012:583123. PMID: 22934209; PMCID: PMC3423663.
    63. Zaorsky NG, Malatesta TM, Den RB, Wuthrick E, Ahn PH, Werner-Wasik M, Shi W, Dicker AP, Anne PR, Bar-Ad V, Showalter TN. Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e465-9. PMID: 22704704.
      View in: PubMed
    64. Zaorsky NG, Buyyounouski MK, Li T, Horwitz EM. Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):e13-7. PMID: 22652109; PMCID: PMC3423546.
    65. Zaorsky NG, Li T, Devarajan K, Horwitz EM, Buyyounouski MK. Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method. Cancer. 2012 Nov 15; 118(22):5535-43. PMID: 22544661; PMCID: PMC3410044.
    66. Kleinmann N, Zaorsky NG, Showalter TN, Gomella LG, Lallas CD, Trabulsi EJ. The effect of ethnicity and sexual preference on prostate-cancer-related quality of life. Nat Rev Urol. 2012 Apr 10; 9(5):258-65. PMID: 22487871.
      View in: PubMed
    67. Shen X, Zaorsky NG, Mishra MV, Foley KA, Hyslop T, Hegarty S, Pizzi LT, Dicker AP, Showalter TN. Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions. Future Oncol. 2012 Jan; 8(1):37-54. PMID: 22149034.
      View in: PubMed
    Zaorsky's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _